Advances in Central Serotoninergics

Keyphrases

• 5-HT1A Receptor 100%
• Serotoninergic Agents 100%
• Nausea 66%
• 5-HT1A 66%
• 5-HT2 Receptor 66%
• 5-hydroxytryptamine 66%
• Serotonin 66%
• 5-HT3 Receptor 66%
• Etiology 33%
• Hypertension 33%
• Central Nervous System 33%
• Receptor Antagonist 33%
• Recent Advancements 33%
• Chemotherapy 33%
• Schizophrenia 33%
• Propranolol 33%
• Cancer Treatment 33%
• Inhibitory Action 33%
• Neurotransmitters 33%
• Ligand-receptor Binding 33%
• Autoreceptor 33%
• 8-OH-DPAT 33%
• Migraine 33%
• 5-HT2 33%
• Spiperone 33%
• Anxiety-depression 33%
• Arylpiperazine 33%
• Obsessive-compulsive Disorder 33%
• Medical Problems 33%
• Prophylactic Treatment 33%
• Pindolol 33%
• High-affinity Binding Site 33%
• Induced Hypothermia 33%
• Selective Ligands 33%
• Ketanserin 33%
• Migraine Treatment 33%
• Antidepressant Properties 33%
• Anxiolytic Properties 33%
• 5-HT1A Agonist 33%
• 5-HT1 Receptor 33%
• 5-HT1B Receptor 33%

Neuroscience

• Serotonin 100%
• 5-HT1A Receptor 75%
• Migraine 50%
• 5-HT2 Receptor 50%
• Serotonin 3 Receptor 50%
• 5-HT1A Antagonists 50%
• Central Nervous System 25%
• Binding Site 25%
• Receptor Antagonist 25%
• Autoreceptor 25%
• 8-OH-DPAT 25%
• Agonist 25%
• Antidepressant 25%
• Neurotransmitter 25%
• Obsessive-Compulsive Disorder 25%
• Spiperone 25%
• 5-HT1A Agonists 25%
• 5-HT1B Receptor 25%
• 5-HT1 Receptor 25%
• 5-HT2 Antagonists 25%
• Cerebrovascular Accident 25%
• Receptor 25%
• Propranolol 25%
• Hypothermia 25%
• Ketanserin 25%
• Pindolol 25%
• Hypertension 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Receptor 100%
• Serotonin 57%
• Nausea 28%
• Serotonin 2 Antagonist 28%
• Migraine 28%
• Serotonin 3 Receptor 28%
• Serotonin 1A Antagonist 28%
• Neurotransmitter 14%
• Binding Site 14%
• Antidepressant 14%
• Spiperone 14%
• Hypothermia 14%
• Cancer Chemotherapy 14%
• Obsessive Compulsive Disorder 14%
• Propranolol 14%
• Cerebrovascular Accident 14%
• Ketanserin 14%
• Autoreceptor 14%
• Serotonin 1A Agonist 14%
• Pindolol 14%
• 8-OH-DPAT 14%
• Diseases 14%